Vanta/Seqenita LT Clinician Programmer Application, Neurostimulation systems for pain therapy, Mo...

FDA Device Recall #Z-0913-2023 — Class II — December 3, 2022

Recall Summary

Recall Number Z-0913-2023
Classification Class II — Moderate risk
Date Initiated December 3, 2022
Status Ongoing
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Medtronic Neuromodulation
Location Minneapolis, MN
Product Type Devices
Quantity 18 units

Product Description

Vanta/Seqenita LT Clinician Programmer Application, Neurostimulation systems for pain therapy, Model Number CT900C

Reason for Recall

Software anomalies, CP App messages: "Too Many Device Found", "Unexpected Device Error Code 1502", and "System Update Needed, Service Code 303"

Distribution Pattern

Worldwide distribution.

Lot / Code Information

GTIN 00643169890961: Lot/Serial Numbers: NPL1000794, NPL1002295, NPL1002284, NPL1002272, NPL1001670, NPL1001615, NPL1001596, NPL1001588, NPL1001591, NPL1001592, NPL1001583, NPL1001579, NPL1001558, NPL1000777, NPL1000774, NPL1000776, NPL1000453, NPL1000429,

Other Recalls from Medtronic Neuromodulation

Recall # Classification Product Date
Z-2241-2026 Class II Medtronic 2x4 Pocket Adaptor Kit for Deep Brain... May 13, 2026
Z-2240-2026 Class II Medtronic 1x4 Pocket Adaptor Kit for Deep Brain... May 13, 2026
Z-2201-2026 Class II Medtronic SynchroMed Flex Infusion Mode - A810 ... Apr 8, 2026
Z-1043-2026 Class II A71200 Vanta" Clinician Programmer Application ... Dec 3, 2025
Z-0996-2026 Class II Restore Clinician Programmer Application (CP Ap... Nov 20, 2025

Frequently Asked Questions

A software recall means the device's embedded software or firmware has a defect that could affect its performance or safety. Many software recalls are corrected through firmware updates that can be applied without physically replacing the device. For implantable devices, the update may be delivered wirelessly during a routine clinic visit. For external devices, the manufacturer may provide updated software files or replacement units. Contact your healthcare provider to determine whether your specific device and software version are affected and what action is recommended.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.